Mechanistic studies revealed that β-lapachone inhibits cell proliferation, metastasis, glucose metabolism, tumor angiogenesis, and EMT by targeting AKT1 to inactivate the PI3K/AKT/mTOR pathway. The gene discussed is AKT1; the disease is neoplasm.